BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 11, 2007
View Archived Issues
BF-2649 increases wakefulness and cognition in preclinical studies
Read More
Catalyst Biosciences signs research collaboration, license agreements with Wyeth
Read More
MPC-7869 development discontinued in cancer
Read More
NBI-56418 reduces endometriosis symptoms in phase II trial
Read More
Fentora studies show onset of pain relief within 10 minutes
Read More
Novel recombinant malaria vaccine candidate shows potential in preclinical studies
Read More
Vorinostat active in phase II refractory cutaneous T-cell lymphoma trial
Read More
Celgene looks back on 2006 and ahead to 2007
Read More
Low LDL-C linked to high incidence of Parkinson's disease: statins may lower risk for the disease
Read More
Cleviprex phase III safety trials meet objectives
Read More
Prochymal receives fast track designation, set to begin phase III for Crohn's disease
Read More
FDA grants orphan drug status to Xanafide in AML
Read More
Alnylam reveals 2007 goals
Read More
Xenoport provides overview of lead programs
Read More
Hana looks ahead to 2007 goals
Read More
Biolipox selects eoxin inhibitor drug candidate for asthma
Read More
Actelion completes cash tender offer for shares of CoTherix
Read More
MDX-1401 cleared for phase I study in relapsed or refractory Hodgkin's disease
Read More
Anthera cleared to study A-001 in hospitalized patients with sickle cell disease
Read More
Novel anticancer drugs revealed in recent patents
Read More
Doxil approved in Japan for AIDS-related Kaposi's sarcoma
Read More
Korea clears study of VM-106 genetic therapy for chronic granuloma
Read More
PRO-513 gives relief from pain, nausea, photophobia and phonophobia in migraine
Read More
Erbitux plus FOLFIRI increases PFS in metastatic colorectal cancer
Read More
Dll4/Notch blockade leads to nonproductive angiogenesis and tumor hypoxia
Read More
New PPAR agonists emerge from Shionogi R&D
Read More
Sonazoid contrast agent launched in Japan
Read More
TheraSphere approved to treat HCC patients with portal vein thrombosis
Read More
Elaprase approved in E.U. for Hunter's syndrome
Read More